ASC- and caspase-1-deficient C57BL/6 mice do not develop demyelinating disease after infection with Theiler's murine

Dandan Li1, Melanie Bühler1, Sandra Runft1

  • 1Department of Pathology, University of Veterinary Medicine Hannover, Foundation, Bünteweg 17, 30559, Hannover, Germany.

Scientific Reports
|July 6, 2023
PubMed

Insights

The inflammasome pathway, involving Apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1, does not determine resistance to Theiler's murine encephalomyelitis virus-induced demyelinating disease (TMEV-IDD) in C57BL/6 mice. These mice efficiently clear the virus regardless of inflammasome function.

Area of Science:

  • Neuroimmunology
  • Virology
  • Infectious Diseases

Background:

  • Theiler's murine encephalomyelitis virus (TMEV) causes demyelinating disease in susceptible mice, but C57BL/6 (B6) mice are typically resistant due to efficient viral clearance.
  • The inflammasome pathway, crucial for innate immunity, activates proinflammatory cytokines like IL-1β and IL-18.
  • Understanding resistance mechanisms to TMEV-induced demyelinating disease (TMEV-IDD) is vital for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of the inflammasome pathway, specifically Apoptosis-associated speck-like protein containing a CARD (ASC) and caspase-1, in the resistance of C57BL/6 (B6) mice to TMEV-IDD.
  • To determine if inflammasome-mediated cytokine activation contributes to viral clearance and resistance in B6 mice.

Main Methods:

  • Infection of wild type, ASC-deficient, and caspase-1-deficient B6 mice with TMEV.
  • Histological and immunohistochemical analysis of brain tissue.
  • Gene expression analysis using RT-qPCR.
  • Protein analysis using Western Blot to detect cytokine cleavage.

Main Results:

  • ASC- and caspase-1-deficient B6 mice successfully eliminated TMEV and did not develop TMEV-IDD, similar to wild type littermates.
  • No significant differences in IFNβ and cytokine gene expression were observed in the brains of deficient and wild type mice.
  • Western Blot analysis confirmed the cleavage of IL-1β and IL-18 in all infected mice, indicating inflammasome activation was not essential for resistance.

Conclusions:

  • Inflammasome-dependent activation of IL-1β and IL-18 is not a major factor in the resistance of C57BL/6 mice to TMEV-induced demyelinating disease.
  • Viral clearance and resistance in B6 mice against TMEV are likely mediated by inflammasome-independent mechanisms.